MIRENA Drug Patent Profile
✉ Email this page to a colleague
When do Mirena patents expire, and when can generic versions of Mirena launch?
Mirena is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug.
This drug has forty-five patent family members in twenty countries.
The generic ingredient in MIRENA is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mirena
A generic version of MIRENA was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIRENA?
- What are the global sales for MIRENA?
- What is Average Wholesale Price for MIRENA?
Summary for MIRENA
International Patents: | 45 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 71 |
Patent Applications: | 3,711 |
Drug Prices: | Drug price information for MIRENA |
What excipients (inactive ingredients) are in MIRENA? | MIRENA excipients list |
DailyMed Link: | MIRENA at DailyMed |
Recent Clinical Trials for MIRENA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Health Network, Toronto | Phase 2 |
Arkansas Children's Hospital Research Institute | Phase 4 |
Peking University People's Hospital | Phase 2 |
Pharmacology for MIRENA
Drug Class | Progestin Progestin-containing Intrauterine System |
Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for MIRENA
MIRENA is protected by two US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | MIRENA | levonorgestrel | SYSTEM;INTRAUTERINE | 021225-001 | Dec 6, 2000 | RX | Yes | Yes | 11,850,182 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Bayer Hlthcare | MIRENA | levonorgestrel | SYSTEM;INTRAUTERINE | 021225-001 | Dec 6, 2000 | RX | Yes | Yes | 10,561,524 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MIRENA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | MIRENA | levonorgestrel | SYSTEM;INTRAUTERINE | 021225-001 | Dec 6, 2000 | 5,785,053 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MIRENA
See the table below for patents covering MIRENA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Poland | 178474 | ⤷ Subscribe | |
Austria | 235201 | ⤷ Subscribe | |
World Intellectual Property Organization (WIPO) | 2010031900 | ⤷ Subscribe | |
Slovenia | 9520150 | Priprava za vstavitev in namestitev intrauterine naprave (INSERTER FOR THE POSITIONING OF AN INTRAUTERINE DEVICE) | ⤷ Subscribe |
China | 1168626 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MIRENA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 300814 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | 39/2015 | Austria | ⤷ Subscribe | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | 122015000093 | Germany | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
1453521 | C201630040 | Spain | ⤷ Subscribe | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
1453521 | C 2015 029 | Romania | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
MIRENA Market Analysis and Financial Projection Experimental
More… ↓